ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In more than 95% of CML patients, the typical BCR::ABL1 transcript subtypes are e13a2 (b2a2), e14a2 (b3a2), or the simultaneous expression of both) [24, 25].